Therapeutic approaches to activate the canonical Wnt pathway for bone regeneration

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Orthopedics

Background:

• The canonical Wingless-related integration site (Wnt) pathway is crucial for bone formation, presenting therapeutic potential for orthopedic conditions.
• Challenges in Wnt pathway activation include the hydrophobicity of Wnt ligands, complicating protein isolation and purification.
• Existing strategies target extracellular inhibitors (Sclerostin, Dickkopf-1) or use small molecules to enhance Wnt gene expression.

Purpose of the Study:

• To review systemic and localized bioactive approaches for enhancing bone formation and repair via Wnt pathway activation.
• To discuss the therapeutic potential of targeting canonical Wnt for orthopedic applications.
• To explore emerging technologies for future clinical translation.

Main Methods:

• Review of systemic and localized bioactive strategies for Wnt pathway modulation.
• Analysis of antibody-based therapeutics targeting Wnt signaling.
• Examination of synthetic Wnt surrogates and scaffold doping approaches.
• Evaluation of emerging technologies like mRNA therapy and CRISPR-Cas9.

Main Results:

• Various strategies exist to overcome challenges in Wnt ligand handling and achieve pathway activation.
• Antibody therapeutics, synthetic surrogates, and scaffold doping show promise for bone regeneration.
• Emerging technologies like mRNA and CRISPR offer novel avenues for Wnt-targeted therapies.

Conclusions:

• Targeting the canonical Wnt pathway holds significant therapeutic promise for bone formation and repair in orthopedics.
• Overcoming Wnt ligand hydrophobicity and delivery challenges is key to successful therapeutic strategies.
• Innovative approaches such as mRNA therapy and gene editing present exciting future possibilities for clinical translation.